El-Hariry, I., Ying, W., Dai, Y., Foley, K., Song, Z., Wu, X., Liang, R., Zhang, J., Yang, X. (2026). A phase 1, first-in-human, open-label study evaluating the safety, tolerability, pharmacokinetics, and efficacy of RNK08954 in patients with advanced solid tumors with a KRAS G12D mutation.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.729